Korea Electric Power (NYSE:KEP) Stock, Quote.Headers.trade-ideas

Korea Electric Power

Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.

Movers

News

Pre-Market Outlook

Markets

Trading Ideas

GMAB

PGHL

RZLV

ZJYL

Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

What Happened

Large Cap

BLDR

CAVA

KEYS

MSTR

WDAY

These 11 stocks gained significantly last week due to strong earnings and positive market conditions. Many analysts have raised their price targets.

Zoom Video, MicroStrategy And Target Were Among Top 11 Large Cap Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?

Image26

FTRE

MESO

MKSI

MNMD

PENN

Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Korea Electric Power Corporation Common Stock

Korea Electric Power Corp

KEPPEL PAC OAK US REIT by KEPPEL PAC OAK US REIT

KEPLER WEBER SA S/ADR by Kepler Weber SA

Keppel DC REIT

KEPPEL CORP LTD ORD by Keppel Corporation Limited

Keppel Ltd

KEPPEL CORP LTD S/ADR by Keppel Corporation Limited

Keppel REIT

WIIM

CPNG

Shares of companies US-listed South Korean stocks are trading lower after South Korean President Yoon Suk Yeol declared martial law.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.
Shares of Jin Medical International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) fell sharply in today's pre-market trading after jumping around 55% on Friday.
Jin Medical International shares dipped 23.5% to $3.12 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Jin Medical International Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJYL#NASDAQ">ZJYL</a>) shares dipped 21.5% to $3.20 in pre-market trading after jumping around 55% on Friday.</li>
<li>Primega Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) shares declined 10.3% to $15.00 in pre-market trading after gaining more than 5% on Friday.</li>
<li>James Hardie Industries plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHX#NYSE">JHX</a>) shares slipped 6% to $39.49 in pre-market trading after gaining more than 8% on Friday.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) shares declined 5.4% to $7.77 in pre-market trading.</li>
<li>Genmab A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMAB#NASDAQ">GMAB</a>) shares fell 4.3% to $24.44 in pre-market trading after declining around 4% on Friday.</li>
<li>Rezolve AI Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLV#NASDAQ">RZLV</a>) shares declined 4.1% to $6.10 in pre-market trading following a 9% decline on Friday.</li>
<li>NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares fell 2.8% to $5.13 in pre-market trading after declining over 2% on Monday.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40962695/jim-cramer-viking-has-many-ships-coming-in"> Jim Cramer: Viking Has &#8216;Many Ships Coming In&#8217;</a></li>
</ul>

Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday's Pre-Market Session

These eleven large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>CAVA Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) stock gained 25.55% in the last week on better-than-expected Q2 results and raised its FY24 adjusted EBITDA outlook. Also, multiple firms raised their respective <a href="https://www.benzinga.com//node/40528470" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) shares jumped 19.90% after the company reported better-than-expected <a href="https://www.benzinga.com//node/40495102" target="_blank" rel="noreferrer noopener">second-quarter results</a>.</li>
<li>Keysight Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) stock rose 14.29% after it reported better-than-<a href="https://www.benzinga.com//node/40490979" target="_blank" rel="noreferrer noopener">expected&nbsp;third-quarter results</a>.</li>
<li>Toll Brothers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) shares were up 14.05% after the company reported better-than-expected&nbsp;third-quarter results and issued FY24 EPS&nbsp;<a href="https://www.benzinga.com//node/40474111" target="_blank" rel="noreferrer noopener">guidance&nbsp;above estimates</a>. Many analysts increased the <a href="https://www.benzinga.com//node/40511410" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>MicroStrategy Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) stock gained 13.09% last week amid a rise in Bitcoin&#8217;s price.</li>
<li>Workday Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) gained 13.05% on better-than-expected Q2 earnings and the approval of an additional <a href="http://better-than-expected Q2 financial results and" target="_blank" rel="noreferrer noopener">$1 billion stock buyback</a>.</li>
<li>Builders FirstSource, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) stock upped 12.09% following strong July new Home Sales economic data. The Fed&#8217;s indication of interest rate cuts also contributed.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) shares were up 10.59%.</li>
<li>TopBuild Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLD#NYSE">BLD</a>) stock gained 9.92% in the last week, along with other homebuilder stocks that were up following strong New Home Sales economic data for July. Fed&#8217;s indication of interest rate cuts also played a part.</li>
<li>Advanced Drainage Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMS#NYSE">WMS</a>) stock was up 9.87%, along with other construction and homebuilder stocks, following strong July new Home Sales economic data and the Fed&#8217;s indication of interest rate cuts.</li>
<li>Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) shares increased 9.75% after the company reported better-than-expected second-quarter<a href="https://www.benzinga.com//node/40492278" target="_blank" rel="noreferrer noopener"> results and raised its outlook</a>. Several analysts boosted <a href="https://www.benzinga.com//node/40514323" target="_blank" rel="noreferrer noopener">the price target on the stock</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/08/40543907/snowflake-jd-com-and-temu-parent-pdd-are-among-top-8-large-cap-losers-last-week-aug-18-aug-24-are-">Snowflake, JD.com And Temu Parent PDD Are Among Top 8 Large Cap Losers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?</a></li>
</ul>
Image via Shutterstock

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.
Shares of Seritage Growth Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRG#NYSE">SRG</a>) fell sharply in today's pre-market trading after the company reported a <a href="https://www.benzinga.com/quote/SRG/earnings">loss for the first quarter</a>.
The company posted a quarterly loss of 36 cents per share, versus a year-ago loss of $1.13 per share, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Seritage Growth Properties shares dipped 23.6% to $7.12 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Vitesse Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTS#NYSE">VTS</a>) shares declined 10.2% to $21.64 in pre-market trading. Vitesse Energy, last week, posted downbeat quarterly earnings.</li>
<li>Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) shares fell 6.3% to $4.32 in pre-market trading. Chimera Investment announced a 1-for-3 reverse stock split.</li>
<li>Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) shares declined 6% to $31.06 in pre-market trading after the company reported soft first-quarter results and cut its revenue outlook.</li>
<li>Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) shares declined 3.7% to $7.09 in pre-market trading after gaining around 3% on Friday.</li>
<li>Mind Medicine (MindMed) Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) shares fell 3.7% to $8.92 in pre-market trading.</li>
<li>MKS Instruments Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) shares declined 3.4% to $126.02 in pre-market trading as the company reported a proposed private offering of $1 billion of convertible senior notes.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) shares fell 3.3% to $7.29 in pre-market trading after declining 7% on Friday.</li>
<li>PENN Entertainment Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) shares slipped 3% to $15.61 in pre-market trading. B of A Securities analyst Shaun Kelley downgraded PENN Entertainment from Buy to Neutral and lowered the price target from $28 to $17.5.</li>
<li>Burford Capital Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) shares slipped 2.5% to $15.05 in pre-market trading after reporting first-quarter results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38781677/tencent-music-entertainment-stoneco-and-3-stocks-to-watch-heading-into-monday">Tencent Music Entertainment, StoneCo And 3 Stocks To Watch Heading Into Monday</a>
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>

Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday.
Shares of Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) fell sharply in today&rsquo;s pre-market trading after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/APLD/earnings">third-quarter financial results</a>.
Applied Digital posted a quarterly loss of 24 cents per share, versus a year-ago loss of 10 cents per share. The company&rsquo;s quarterly sales came in at $43.35 million versus expectations of $51.92 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Applied Digital shares dipped 9.1% to $2.79 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Tevogen Bio Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tvgn#NASDAQ">TVGN</a>) shares declined 8.5% to $2.26 in pre-market trading.</li>
<li>Nurix Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrix#NASDAQ">NRIX</a>) shares declined 6.3% to $16.12 pre-market trading after the company priced its upsized $175m public offering of 10,166,667 common shares at $15 per share.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) shares fell 4.6% to $7.89 in pre-market trading.</li>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) shares fell 3.7% to $3.10 in pre-market trading.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) shares declined 3.2% to $7.54 in pre-market trading after falling over 3% on Thursday.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) shares fell 3.1% to $2.24 in pre-market trading after dipping 8% on Thursday.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) shares fell 3% to $26.20 in pre-market trading.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38215285/citigroup-jpmorgan-and-3-stocks-to-watch-heading-into-friday"> Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Friday </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Penny Stocks

Small Cap

APLD

ESPR

NRIX

TSHA

TVGN

XPEV

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Korea Electric Power shares are trading lower amid weakness in Korean stocks.

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.
Shares of Walmart Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wmt#NYSE">WMT</a>) rose in today&rsquo;s session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/02/37213218/walmart-q4-performance-revenue-and-eps-surprise-dividend-hike-vizio-buyout-and-more">fourth-quarter financial results.</a>
Walmart reported fourth-quarter FY24 net sales growth of 5.7% year-over-year to $173.39 billion, beating the consensus of $170.71 billion. Adjusted EPS was $1.80, beating the consensus of $1.65.
The board approved an annual cash dividend for fiscal year 2025 of 83 cents per share on a post-stock split basis or $2.49 per share on a pre-split basis, approximately a 9% increase from the $2.28 per share paid for the last fiscal year.
Walmart shares gained 4.9% to $178.66 on Tuesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) shares jumped 37% to $12.55. WuXi Advanced Therapies announced Tuesday that the U.S. Food and Drug Administration (FDA) approved it to begin analytical testing and manufacturing of AMTAGVI for Iovance Biotherapeutics at its Philadelphia site. AMTAGVI received accelerated approval of its BLA on Feb. 16. Iovance also announced on Tuesday the pricing of an underwritten offering of 23,014,000 shares of its common stock at a price of $9.15 per share.</li>
<li>Phathom Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phat#NASDAQ">PHAT</a>) gained 15.1% to $10.70.</li>
<li>VIZIO Holding Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vzio#NYSE">VZIO</a>) rose 14.8% to $10.94 after the company inked an agreement to be acquired by Walmart.</li>
<li>Discover Financial Services (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dfs#NYSE">DFS</a>) shares climbed 12% to $13.00. Capital One Financial Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cof#NYSE">COF</a>) announced its plans to purchase Discover Financial Services, marking a pivotal $35.3 billion all-stock transaction.</li>
<li>Barclays PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bcs#NYSE">BCS</a>) gained 11.7% to $8.35 after the company reported fourth-quarter financial results and announced its intention to initiate a further share buyback of up to &pound;1 billion.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) rose 10.7% to $8.74</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrtea#NASDAQ">QRTEA</a>) surged 10.6% to $1.15.</li>
<li>InterContinental Hotels Group PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihg#NYSE">IHG</a>) gained 8.3% to $105.83.</li>
<li>Armstrong World Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/awi#NYSE">AWI</a>) jumped 8.1% to $113.63 following upbeat results.</li>
<li>Telephone and Data Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tds#NYSE">TDS</a>) rose 7.7% to $15.13. The company recently reported fourth-quarter financial results and issued FY24 guidance.</li>
<li>Owens &amp; Minor, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omi#NYSE">OMI</a>) gained 7.7% to $22.84 after the company reported better than expected fourth-quarter earnings and issued 2024 guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37205506/leidos-holdings-vulcan-materials-and-more-on-cnbcs-final-trades"> Leidos Holdings, Vulcan Materials And More On CNBC&#39;s &#39;Final Trades&#39; </a>

Intraday Update

IOVA

PHAT

QRTEA

VZIO

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

As of Feb. 8, 2024, four stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>)</h3>
<ul>
<li>The company&rsquo;s stock gained around 7% over the past month and has a <a href="https://www.benzinga.com/quote/KEP">52-week high of $8.10 </a>.</li>
<li>RSI Value: 73.44</li>
<li>KEP Price Action: Shares of Korea Electric Power gained 1.7% to close at $7.92 on Wednesday.</li>
</ul>
<h3>Vistra Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vst#NYSE">VST</a>)</h3>
<ul>
<li>On Dec. 12, Vistra priced upsized private offerings of $400 million 6.950% senior secured notes due 2033 and $350 million 7.750% senior unsecured notes due 2031. The company&rsquo;s stock gained around 12% over the past month and <a href="https://www.benzinga.com/quote/VST"> has a 52-week high </a> of $44.96.</li>
<li>RSI Value: 72.90</li>
<li>VST Price Action: Shares of Vistra gained 1.2% to close at $43.76 on Wednesday.</li>
</ul>
<h3>Constellation Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceg#NASDAQ">CEG</a>)</h3>
<ul>
<li>On Dec. 14, Constellation Energy announced the board approved a $1 billion increase to the company&#39;s previously announced $1 billion repurchase program. The company&rsquo;s stock gained around 9% over the past five days and has a <a href="https://www.benzinga.com/quote/CEG"> 52-week high </a> of $133.80.</li>
<li>RSI Value: 73.77</li>
<li>CEG Price Action: Shares of Constellation Energy gained 1.1% to close at $132.50 on Wednesday.</li>
</ul>
<h3>Otter Tail Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ottr#NASDAQ">OTTR</a>)</h3>
<ul>
<li>On Feb. 5, Otter Tail raised its quarterly common stock dividend from 43.75 cents to 46.75 cents per share. The company&rsquo;s stock jumped around 10% over the past month and has a 52-week high is $95.99.</li>
<li>RSI Value: 72.48</li>
<li>OTTR Price Action: Shares of Otter Tail gained 0.7% to close at $94.81 on Wednesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/02/36999219/conocophillips-disney-and-3-stocks-to-watch-heading-into-thursday"> ConocoPhillips, Disney And 3 Stocks To Watch Heading Into Thursday </a>

Short Ideas

OTTR

Top 4 Utilities Stocks You May Want To Dump This Month

As of Nov. 27, 2023, five stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Via Renewables, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/via#NASDAQ">VIA</a>)</h3>
<ul>
<li>Via Renewables posted a profit for the third quarter. &quot;Via was able to navigate one of the hottest ERCOT summers on record due to our proven risk management policies and portfolio diversification. We&#39;ve been able to stay financially flexible while paying down debt and boosting liquidity since last quarter,&quot; said Keith Maxwell, Via Renewables&#39; President and Chief Executive Officer. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/VIA">52-week high of $37.35. </a>.</li>
<li>RSI Value: 73.25</li>
<li>VIA Price Action: Shares of Via Renewables rose 1.2% to close at $9.25 on Friday.</li>
</ul>
<h3>Public Service Enterprise Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/peg#NYSE">PEG</a>)</h3>
<ul>
<li>Public Service Enterprise posted upbeat third-quarter earnings. &quot;PSEG posted solid operating and financial results for the third quarter, and is on pace to achieve our guidance for full-year, 2023 non-GAAP Operating Earnings of $3.40 to $3.50 per share &ndash; which we are re-affirming today,&quot; said Ralph LaRossa, PSEG&#39;s chair, president and CEO. The company&rsquo;s <a href="https://www.benzinga.com/quote/PEG"> stock has a 52-week high </a> of $65.46.</li>
<li>RSI Value: 70.52</li>
<li>PEG Price Action: Shares of Public Service Enterprise gained 0.7% to close at $65.09 on Friday.</li>
</ul>
<h3>DTE Energy Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dte#NYSE">DTE</a>)</h3>
<ul>
<li>DTE Energy reported worse-than-expected third-quarter EPS results and lowered FY23 operating EPS guidance. &ldquo;This year we were faced with unprecedented headwinds which impacted our 2023 operating EPS guidance, but through the incredible work of our highly engaged team, DTE continues to be in a good position to offset the majority of the challenges and continue to deliver for our customers, our community and our investors,&rdquo; Jerry Norcia, DTE Energy Chairman and CEO, said. The company has a <a href="https://www.benzinga.com/quote/DTE"> 52-week high </a> of $122.41.</li>
<li>RSI Value: 71.48</li>
<li>DTE Price Action: Shares of DTE Energy rose 0.7% to close at $105.37 on Friday.</li>
</ul>
<h3>Consolidated Water Co. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cwco#NASDAQ">CWCO</a>)</h3>
<ul>
<li>Consolidated Water reported better-than-expected third-quarter results. &ldquo;In Q3, we reported another solid quarter of results for both revenue and earnings,&rdquo; stated Consolidated Water CEO, Rick McTaggart. &ldquo;The nearly 100% increase in revenue to $49.9 million was due to strong growth across our services, retail water, and manufacturing business segments.&rdquo; The company&rsquo;s 52-week high is $36.70.</li>
<li>RSI Value: 72.95</li>
<li>CWCO Price Action: Shares of Consolidated Water gained 0.8% to close at $36.08 on Friday.</li>
</ul>
<h3>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>)</h3>
<ul>
<li>The company&rsquo;s stock jumped around 12% over the past month. The company <a href="https://www.benzinga.com/quote/KEP"> has a 52-week high </a> of $8.85.</li>
<li>RSI Value: 74.88</li>
<li>KEP Price Action: Shares of Korea Electric Power gained 3.2% to close at $7.20 on Friday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/11/35935872/how-to-earn-500-a-month-from-deere-stock-following-upbeat-earnings"> How To Earn $500 A Month From Deere Stock Following Upbeat Earnings </a>

CWCO

Top 5 Utilities Stocks That May Fall Off A Cliff In November

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today&rsquo;s session.
<ul>
<li>Gorilla Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grrr#NASDAQ">GRRR</a>) shares fell 66% to $4.0150.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) tumbled 23.6% to $5.19. Ensysce Biosciences posted a Q4 loss of $1.52 per share.</li>
<li>AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>) shares dropped 21.2% to $5.04 after the company posted a wider Q4 loss.</li>
<li>Annovis Bio, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NYSE">ANVS</a>) fell 20.4% to $16.00. Annovis Bio received interim analysis for sample size re-estimation for its Phase 3 clinical trial for treatment of early Parkinson&#39;s disease.</li>
<li>Disc Medicine Opco Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iron#NASDAQ">IRON</a>) dropped 15% to $18.69 after the company reported full year 2022 financial results.</li>
<li>Zura Bio Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zura#NASDAQ">ZURA</a>) declined 14.4% to $13.55.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) fell 12.5% to $32.56 following Q3 results.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) dipped 12.5% to $1.22 after the company announced pricing for a $100 million common stock offering.</li>
<li>IGM Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igms#NASDAQ">IGMS</a>) dropped 12% to $14.98 after the company reported Q4 financial results.</li>
<li>Target Hospitality Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/th#NASDAQ">TH</a>) fell 11.3% to $13.68. Northland Capital Markets maintained Target Hospitality with an Outperform and lowered the price target from $26 to $20.</li>
<li>Arco Platform Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arce#NASDAQ">ARCE</a>) dropped 9.7% to $11.17. Arco Platform posted Q4 revenue of R$679.3 million, up 47.4% year over year.</li>
<li>TROOPS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/troo#NASDAQ">TROO</a>) fell 7.7% to $3.23.</li>
<li>Avidity Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rna#NASDAQ">RNA</a>) dropped 6.6% to $15.70. Avidity Biosciences announced its decision to conclude the Phase 1/2 MARINA trial with the 38 participants enrolled at 1mg ,2mg and 4mg/kg of AOC 1001 and not to move forward with the 8 mg/kg dose in DM1.</li>
<li>Studio City International Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msc#NYSE">MSC</a>) fell 5.8% to $6.31.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) dropped 5.5% to $6.91.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/23/03/31609141/ethereum-trades-above-this-key-level-hedera-rocket-pool-among-top-gainers"> Ethereum Trades Above This Key Level; Hedera, Rocket Pool Among Top Gainers</a>

AEHR

ANVS

ARCE

ASTS

ENSC

GRRR

IGMS

IRON

NKLA

TROO

ZURA

Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Thursday.
The Dow traded up 0.31% to 32,764.50 while the NASDAQ fell 0.49% to 11,324.28. The S&amp;P 500 also fell, dropping, 0.21% to 3,943.00.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/03/31167531/top-5-materials-stocks-that-could-lead-to-your-biggest-gains-in-march"> Top 5 Materials Stocks That Could Lead To Your Biggest Gains In March</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
<ul>
<li>Utilities shares rose 0.7% on Thursday. Meanwhile, top gainers in the <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a> included Enel Chile S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/enic#NYSE">ENIC</a>), up 2%, and Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>), up 1%.</li>
<li>In trading on Thursday, financial shares fell by 1.2%.</li>
</ul>
&nbsp;
<h3>Top Headline</h3>
Macy&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) reported better-than-expected Q4 adjusted EPS and sales results and issued guidance.
Macy&#39;s reported a sales decline of 4.6% year-on-year to $8.26 billion, beating the consensus of $8.25 billion. Adjusted EPS of $1.88 beat the consensus of $1.57.
&nbsp;
<h3>Equities Trading UP</h3>
<ul>
<li>BioRestorative Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brtx#NASDAQ">BRTX</a>) shares shot up 37% to $3.82 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company&#39;s metabolic ThermoStem program.</li>
<li>Shares of Diversified Healthcare Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dhc#NASDAQ">DHC</a>) got a boost, shooting 45% to $1.3450 after the company reported better-than-expected Q4 sales results.</li>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) shares were also up, gaining 40% to $0.0681 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions.</li>
</ul>
&nbsp;
<h3>Equities Trading DOWN</h3>
<ul>
<li>ZimVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zimv#NASDAQ">ZIMV</a>) shares tumbled 39% to $6.37 after the company reported worse-than-expected Q4 adjusted EPS and sales results and issued FY23 adjusted EPS and net sales guidance below estimates.</li>
<li>Shares of Silvergate Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/si#NYSE">SI</a>) were down 46% to $7.28 after the company delayed the filing of its Form 10-K with the SEC.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) was down, falling 22% to $1.2150 after the company reported worse-than-expected Q4 earnings and issued weak FY23 revenue guidance.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/23/03/31168985/insiders-selling-airbnb-sp-plus-and-2-other-stocks"> Insiders Selling Airbnb, SP Plus And 2 Other Stocks</a>
&nbsp;
<h3>Commodities</h3>
In commodity news, oil traded up 0.7% to $78.24 while gold traded down 0.1% at $1,845.00.
Silver traded down 0.3% to $21.01 on Thursday while copper fell 1.7% to $4.0890.
&nbsp;
<h3>Euro zone</h3>
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.40%, London&rsquo;s FTSE 100 rose 0.30% while Spain&rsquo;s IBEX 35 Index fell 0.06%. The German DAX gained 0.08% French CAC 40 rose 0.55% and Italy&rsquo;s FTSE MIB Index gained 0.27%.
France&rsquo;s government budget deficit increased to EUR 21.2 billion in January from EUR 16 billion in the year-ago period.
&nbsp;
<h3>Asia Pacific Markets</h3>
Asian markets closed lower on Thursday, with Japan&rsquo;s Nikkei 225 dropping 0.06%, Hong Kong&rsquo;s Hang Seng Index dropping 0.92% and China&rsquo;s Shanghai Composite Index declining 0.05%. India&rsquo;s S&amp;P BSE Sensex dropped 0.8%.
Retail sales in Hong Kong rose 5.1% year-over-year in January following a revised 0.6% drop in the prior month. The consumer confidence index in Japan rose to 31.1 in February from 31.0 in the prior month.
&nbsp;
<h3>Economics</h3>
<ul>
<li>US jobless claims fell by 2,000 from the prior week to 190,000 for the week ending Feb. 25, compared to market estimates of 195,000.</li>
<li>Unit labor costs rose by an annualized 3.2% in the fourth quarter, while nonfarm business <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a> labor productivity growth was revised lower to 1.7% in the quarter.</li>
<li>US natural-gas supplies declined 81 billion cubic feet during the week ended Feb. 24, 2023, the EIA said.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/03/31162769/dell-likely-to-report-lower-quarterly-earnings-heres-a-look-at-recent-price-target-changes-by-the-m"> Dell Likely To Report Lower Quarterly Earnings, Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts</a>
&nbsp;
<h3>COVID-19 Update</h3>
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 105,345,990 cases with around 1,146,140 deaths. India confirmed a total of at least 44,686,870 cases and 530,770 deaths, while France reported over 39,626,750 COVID-19 cases with 164,980 deaths. In total, there were at least 680,206,720 cases of COVID-19 worldwide with more than 6,801,720 deaths.

Earnings

Eurozone

Commodities

Global

BRTX

CANO

ENIC

XELA

ZIMV

Dow Rises 100 Points; Macy's Posts Upbeat Earnings

If history is any guide, there may be good fortune ahead for shares of Korea Electric Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
What To Know: Many traders use moving average crossover systems to make their decisions.
When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term average price, it means the trend is lower.
Why It's Important: The 50-day and the 200-day simple moving averages are commonly used. 
The golden cross occurs when the 50-day crosses above the 200-day. This could mean the long-term trend is changing.
That just happened with Korea Electric Power, which is trading around $8.27 at publication time.
<img src="https://www.benzinga.com/files/images/story/2023/1674744468_0.png" alt="signals" />
Remember: Seasoned investors don't blindly trade Golden Crosses.
Instead, they use it as a signal to start looking for long positions based on other factors, like price levels and company fundamentals &amp; events.
For seasoned investors, this is just a sign that it might be time to start considering possible long positions. 
[TABLE]
Do you use the Golden Cross signal in your trading or investing? Share this article with a friend if you found it helpful!
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Golden Cross Appears Before Korea Electric Power Investors

<h3>Gainers</h3>
<ul>
<li>Horizon Global Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzn#NYSE">HZN</a>) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.</li>
<li>Jasper Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jspr#NASDAQ">JSPR</a>) gained 257% to $1.70 after the company announced clinical data from a Phase I/II trial of briquilimab as a conditioning treatment in sickle cell disease and beta thalassemia.</li>
<li>ReShape Lifesciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rsls#NASDAQ">RSLS</a>) shares jumped 142.3% to $16.34. Reshape Lifesciences recently announced a 1-for-50 reverse stock split.</li>
<li>Lucira Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lhdx#NASDAQ">LHDX</a>) surged 68% to $0.1875 after the company announced it submitted an Emergency Use Authorization application to the FDA for OTC use of its COVID-19 &amp; Flu test.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) shares gained 43% to $0.1958 after the company reported commencement of strategic review process.</li>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) jumped 41% to $0.5678. Vivos Therapeutics recently posted a Q3 loss of $0.26 per share.</li>
<li>EpicQuest Education Group International Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eeiq#NASDAQ">EEIQ</a>) gained 40.1% to $3.0962.</li>
<li>Scilex Holding Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sclx#NASDAQ">SCLX</a>) jumped 40.1% to $5.59.</li>
<li>Galmed Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glmd#NASDAQ">GLMD</a>) surged 33.8% to $0.6690.</li>
<li>Aurinia Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auph#NASDAQ">AUPH</a>) gained 33.4% to $5.76. Aurinia said LUPKYNIS&reg; (voclosporin) patent challenge settlement has been reached with Sun Pharmaceuticals.</li>
<li>Navidea Biopharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/navb#NYSE">NAVB</a>) rose 33.3% to $0.28. Navidea Biopharmaceuticals announced the notice of allowance for U.S. patent application for key component of the company&#39;s cancer immunotherapy pipeline.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmmb#NASDAQ">CMMB</a>) gained 32% to $4.24 after the company reported top-line results from the CM-101 Phase 2a liver fibrosis biomarker trial in NASH patients. The trial met its primary endpoint.</li>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) jumped 29% to $0.1810 after the company announced publication of data from the Phase 2 data study of RHB-107 in non-hospitalized COVID-19 patients. The study met the primary endpoint of safety and tolerability.</li>
<li>ACM Research, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acmr#NASDAQ">ACMR</a>) gained 28.7% to $9.92 after the company issued FY23 revenue guidance above estimates.</li>
<li>Checkpoint Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ckpt#NASDAQ">CKPT</a>) gained 27.7% to $6.52.</li>
<li>Sorrento Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) rose 25.2% to $1.1098. Sorrento Therapeutics, last month, received FDA clearance to initiate clinical trials with a next generation mRNA vaccine against omicron SARS-CoV-2 virus.</li>
<li>180 Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atnf#NASDAQ">ATNF</a>) shares gained 24% to $4.2009.</li>
<li>Dada Nexus Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dada#NYSE">DADA</a>) jumped 21.6% to $8.48.</li>
<li>Boxed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boxd#NYSE">BOXD</a>) gained 20% to $0.2346.</li>
<li>Gorilla Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grrr#NASDAQ">GRRR</a>) shares gained 18% to $9.57 after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal.</li>
<li>T Stamp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idai#NASDAQ">IDAI</a>) gained 15% to $0.5887.</li>
<li>NaaS Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/naas#NASDAQ">NAAS</a>) jumped 14.9% to $4.47. NaaS Technology appointed Alex Wu as its Chief Financial Officer, effective January 15, 2023.</li>
<li>Getaround, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/getr#NYSE">GETR</a>) rose 14.3% to $0.7481 after gaining more than 30% on Friday. Piper Sandler recently initiated coverage on Getaround with an Overweight rating and announced a price target of $1.5.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) gained 14.3% to $27.08.</li>
<li>IM Cannabis Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) gained 13.1% to $1.12.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) jumped 12.5% to $23.20.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) shares rose 8% to $0.3089 after gaining over 8% on Friday.</li>
<li>Cosmos Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cosm#NASDAQ">COSM</a>) rose 8% to $4.93. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.</li>
<li>Novo Integrated Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvos#NASDAQ">NVOS</a>) rose 7.9% to $0.2169. Novo Integrated Sciences recently announced receipt of notice from Nasdaq.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) rose 7.7% to $10.72. XPeng sold 11,292 units for December and 22,204 units for the fourth quarter.</li>
<li>Cellectis S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clls#NASDAQ">CLLS</a>) rose 7.1% to $2.25 after gaining around 8% on Friday.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) rose 3.8% to $21.17. Li Auto said it delivered 21,233 vehicles in December, marking a record monthly performance. In the fourth quarter, the company sold 46,319 cars.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Dermata Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drma#NASDAQ">DRMA</a>) shares fell 20.7% to $0.3243. Dermata Therapeutics shares jumped over 100% on Friday after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.</li>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) dropped 19% to $1.43 after climbing around 72% on Friday.</li>
<li>Inter &amp; Co, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intr#NASDAQ">INTR</a>) fell 17.7% to $1.9501.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) fell 17.6% to $0.8897 after jumping around 19% on Friday. Argo Blockchain recently entered into definitive agreements with Galaxy Digital Holdings, under which an Argo subsidiary will sell its Helios facility in Dickens County, Texas for $65 million.</li>
<li>Mammoth Energy Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tusk#NASDAQ">TUSK</a>) dropped 17.3% to $7.15.</li>
<li>Valens Semiconductor Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vln#NYSE">VLN</a>) fell 17% to $4.4800.</li>
<li>Palisade Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pali#NASDAQ">PALI</a>) fell 16.4% to $4.3494. Palisade Bio recently announced $2.5 million registered direct offering and concurrent private placement priced above market under Nasdaq rules.</li>
<li>PDS Biotechnology Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pdsb#NASDAQ">PDSB</a>) dropped 15.3% to $11.18. PDS Biotech announced exclusive global license agreement for investigational IL-12 tumor-targeted cytokine from Merck KGaA, Darmstadt, Germany.</li>
<li>Prelude Therapeutics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prld#NASDAQ">PRLD</a>) fell 13.9% to $5.20.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) fell 13.7% to $6.70.</li>
<li>Fuwei Films (Holdings) Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rtc#NASDAQ">RTC</a>) fell 12.7% to $7.88.</li>
<li>Arqit Quantum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqq#NASDAQ">ARQQ</a>) fell 11.9% to $3.18.</li>
<li>Kala Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kala#NASDAQ">KALA</a>) shares fell 11.3% to $33.83 after gaining over 53% on Friday. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) shares fell 10.4% to $7.74.</li>
<li>Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) fell 10.3% to $110.54 after the company reported fourth-quarter deliveries that came in below market estimates. The company delivered more than 405,278 cars in the fourth quarter, and produced over 439,000. This represented a 31.33% year-over-year rise and a 17.87% sequential growth. The consensus estimate for Q4 deliveries compiled by Tesla&rsquo;s investor relations was 417,957 units.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) fell 9.8% to $2.11 after jumping 18% on Friday.</li>
<li>Nu Holdings Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nu#NYSE">NU</a>) fell 8.2% to $3.7392.</li>
<li>Silo Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silo#NASDAQ">SILO</a>) fell 6.3% to $3.15. Silo Pharma, on Friday, reported interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents.</li>
</ul>
Also Check This Out <a href="https://www.benzinga.com/news/earnings/23/01/30258235/wall-street-starts-2023-on-positive-note"> Wall Street Starts 2023 On Positive Note</a>

ACMR

ARBK

ARQQ

ATNF

AUPH

BILI

BIVI

BOXD

CKPT

CLLS

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

COSM

DADA

DRMA

EEIQ

GETR

GLMD

IDAI

IMCC

INTR

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

KALA

LHDX

MULN

NAAS

NAVB

NVOS

PALI

PDSB

PRLD

RDHL

RSLS

SCLX

SILO

SOUN

SRNE

SWVL

TBLT

TSLA

TUSK

VVOS

Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today&rsquo;s session.
<ul>
<li>SoundHound AI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soun#NASDAQ">SOUN</a>) shares dipped 19% to $1.43 after climbing around 72% on Friday.</li>
<li>Inter &amp; Co, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intr#NASDAQ">INTR</a>) dropped 17.7% to $1.9501.</li>
<li>Mammoth Energy Services, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tusk#NASDAQ">TUSK</a>) fell 17.3% to $7.15.</li>
<li>Valens Semiconductor Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vln#NYSE">VLN</a>) declined 17% to $4.4800.</li>
<li>PDS Biotechnology Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pdsb#NASDAQ">PDSB</a>) fell 15.3% to $11.18. PDS Biotech announced exclusive global license agreement for investigational IL-12 tumor-targeted cytokine from Merck KGaA, Darmstadt, Germany.</li>
<li>Arqit Quantum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqq#NASDAQ">ARQQ</a>) dropped 11.9% to $3.18.</li>
<li>Verona Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrna#NASDAQ">VRNA</a>) declined 11.1% to $23.22.</li>
<li>Pulmonx Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lung#NASDAQ">LUNG</a>) fell 11% to $7.50. B of A Securities downgraded Pulmonx from Neutral to Underperform and announced an $8 price target.</li>
<li>Natura &amp;Co Holding S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ntco#NYSE">NTCO</a>) dropped 10.6% to $3.87.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) shares fell 10.4% to $7.74.</li>
<li>Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) fell 10.3% to $110.54 after the company reported fourth-quarter deliveries that came in below market estimates. The company delivered more than 405,278 cars in the fourth quarter, and produced over 439,000. This represented a 31.33% year-over-year rise and a 17.87% sequential growth. The consensus estimate for Q4 deliveries compiled by Tesla&rsquo;s investor relations was 417,957 units.</li>
<li>Petr&oacute;leo Brasileiro S.A. &ndash; Petrobras (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbr#NYSE">PBR</a>) fell 9.2% to $9.68.</li>
<li>Tidewater Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdw#NYSE">TDW</a>) declined 8.6% to $33.62.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) dropped 8.3% to $1.2550.</li>
<li>Nu Holdings Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nu#NYSE">NU</a>) fell 8.2% to $3.7392.</li>
<li>Olink Holding AB (publ) (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olk#NASDAQ">OLK</a>) fell 8% to $23.34.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) dropped 7.4% to $49.04.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/23/01/30257984/crypto-market-cap-tops-800-billion-kava-solana-among-top-gainers"> Crypto Market Cap Tops $800 Billion; Kava, Solana Among Top Gainers</a>

LUNG

NTCO

VRNA

PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday

<h3>Gainers</h3>
<ul>
<li>Gorilla Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grrr#NASDAQ">GRRR</a>) shares rose 162% to $21.30 in pre-market trading after jumping over 35% on Friday. Gorilla Technology recently said it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) shares rose 68% to $0.2302 in pre-market trading after the company reported commencement of strategic review process.</li>
<li>Novo Integrated Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvos#NASDAQ">NVOS</a>) rose 49.1% to $0.2999 in pre-market trading. Novo Integrated Sciences recently announced receipt of notice from Nasdaq.</li>
<li>Sorrento Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) rose 33.2% to $1.18 in pre-market trading. Sorrento Therapeutics, last month, received FDA clearance to initiate clinical trials with a next generation mRNA vaccine against omicron SARS-CoV-2 virus.</li>
<li>Unicycive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uncy#NASDAQ">UNCY</a>) shares rose 16.7% to $0.63 in pre-market trading. Unicycive recently reported termination of &#39;at-the-market&#39; offering of shares of common stock.</li>
<li>Cosmos Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cosm#NASDAQ">COSM</a>) rose 16% to $5.29 in pre-market trading. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.</li>
<li>Kala Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kala#NASDAQ">KALA</a>) rose 14.1% to $43.53 in pre-market trading after gaining over 53% on Friday. Kala Pharmaceuticals recently announced FDA acceptance of an IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) rose 14.1% to $1.03 in pre-market trading after declining around 4% on Friday.</li>
<li>Aethlon Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aemd#NASDAQ">AEMD</a>) rose 12.6% to $0.31 in pre-market trading after gaining around 7% on Friday.</li>
<li>Rubius Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ruby#NASDAQ">RUBY</a>) rose 10.4% to $0.19 in pre-market trading after declining 9% on Friday.</li>
<li>Cellectis S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clls#NASDAQ">CLLS</a>) rose 10.3% to $2.32 in pre-market trading after gaining around 8% on Friday.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) shares rose 9.4% to $0.3130 in pre-market trading after gaining over 8% on Friday.</li>
<li>Meiwu Technology Company Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wnw#NASDAQ">WNW</a>) rose 8.7% to $0.2076 in pre-market trading after declining 5% on Friday.</li>
<li>NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) rose 8.7% to $0.78 in pre-market trading after gaining more than 6% on Friday.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) rose 7.3% to $21.88 in pre-market trading. Li Auto said it delivered 21,233 vehicles in December, marking a record monthly performance. In the fourth quarter, the company sold 46,319 cars.</li>
<li>Getaround, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/getr#NYSE">GETR</a>) rose 7.3% to $0.70 in pre-market trading after gaining more than 30% on Friday. Piper Sandler recently initiated coverage on Getaround with an Overweight rating and announced a price target of $1.5.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) rose 6.7% to $10.61 in pre-market trading. XPeng sold 11,292 units for December and 22,204 units for the fourth quarter.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) rose 5.7% to $1.31 in pre-market trading after dropping around 7% on Friday.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) rose 4.2% to $10.16 in pre-market trading as the company reported that it delivered 15,815 vehicles in December, marking a new record-high monthly delivery, and also representing a 50.8% year-over-year growth. It delivered 40,052 vehicles during the fourth quarter, representing a surge of 60.0% year-over-year.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Bit Brother Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btb#NASDAQ">BTB</a>) shares fell 17.2% to $8.80 in pre-market trading after gaining over 9% on Friday. Bit Brother, last month, announced a 1-for-15 reverse share split.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) fell 14.9% to $0.9187 in pre-market trading after jumping around 19% on Friday. Argo Blockchain recently entered into definitive agreements with Galaxy Digital Holdings, under which an Argo subsidiary will sell its Helios facility in Dickens County, Texas for $65 million.</li>
<li>Silo Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/silo#NASDAQ">SILO</a>) fell 14.8% to $2.86 in pre-market trading. Silo Pharma, on Friday, reported interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drma#NASDAQ">DRMA</a>) shares fell 12% to $0.36 in pre-market trading. Dermata Therapeutics shares jumped over 100% on Friday after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) fell 10.8% to $0.60 in pre-market trading after gaining 18% on Friday. TransCode Therapeutics recently announced it received written authorization from the FDA that it may proceed with its First-in-Human Phase 0 clinical trial.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) fell 9.4% to $2.12 in pre-market trading after jumping 18% on Friday.</li>
<li>GreenLight Biosciences Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grna#NASDAQ">GRNA</a>) fell 9.3% to $1.07in pre-market trading after gaining over 5% on Friday.</li>
<li>Sphere 3D Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/any#NASDAQ">ANY</a>) fell 9.2% to $0.2501 in pre-market trading.</li>
<li>Aeglea BioTherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agle#NASDAQ">AGLE</a>) fell 8.8% to $0.41 in pre-market trading after gaining 26% on Friday.</li>
<li>Reed&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reed#NASDAQ">REED</a>) fell 8.5% to $0.0638 in pre-market trading.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) shares fell 8% to $7.95 in pre-market trading.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) shares fell 5.5% to $11.18 in pre-market trading after gaining around 14% on Friday. B. Riley Securities maintained a Buy rating on the stock and raised its price target from $17 to $23.</li>
<li>Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) fell 4.2% to $118.05 in pre-market trading after the company reported fourth-quarter deliveries that came in below market estimates. The company delivered more than 405,278 cars in the fourth quarter, and produced over 439,000. This represented a 31.33% year-over-year rise and a 17.87% sequential growth. The consensus estimate for Q4 deliveries compiled by Tesla&rsquo;s investor relations was 417,957 units.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/01/30252582/investor-fear-eases-slightly-on-last-trading-day-of-2022"> Investor Fear Eases Slightly On Last Trading Day Of 2022</a>

AEMD

AGLE

AIHS

GRNA

NRBO

REED

RNAZ

RUBY

TGTX

UNCY

Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Ambrx Biopharma Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amam#NYSE">AMAM</a>) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.</li>
<li>ClearOne, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clro#NASDAQ">CLRO</a>) gained 85% to $1.51 after the company and Shure Incorporated announced they reached a global settlement of all pending legal disputes.</li>
<li>Rockley Photonics Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rkly#NYSE">RKLY</a>) rose 48.3% to $0.4218 after jumping 18% on Thursday. Rockley Photonics, last month, reported worse-than-expected Q3 sales results and issued 2022 revenue guidance below estimates.</li>
<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ">MRIN</a>) shares climbed 34.5% to $1.52. Marin Software joined the Walmart Platform Partner program as an API partner.</li>
<li>UpHealth, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uph#NYSE">UPH</a>) shares climbed 30.6% to $3.06. Healthcare transformation expert Timothy Wilde joined UpHealth as Chief Technology Officer.</li>
<li>China Jo-Jo Drugstores, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjjd#NASDAQ">CJJD</a>) gained 29.4% to $2.7953.</li>
<li>Hello Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/momo#NASDAQ">MOMO</a>) jumped 29% to $8.77. Morgan Stanley upgraded Hello Group from Equal-Weight to Overweight and raised the price target from $5 to $9.</li>
<li>Arcellx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aclx#NASDAQ">ACLX</a>) gained 27.8% to $27.71. Kite, a Gilead Sciences Inc company, announced a global strategic collaboration to co-develop and co-commercialize Arcellx&rsquo;s lead late-stage product candidate, CART-ddBCMA, for relapsed or refractory multiple myeloma. Arcellx also announced interim CART-ddBCMA Phase 1 results (October 31, 2022 cutoff date), demonstrating deep and durable responses.</li>
<li>Baudax Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bxrx#NASDAQ">BXRX</a>) shares gained 23% to $5.01 after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.</li>
<li>Daktronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dakt#NASDAQ">DAKT</a>) jumped 23% to $2.1518. Daktronics delayed its earnings release to address the determination that there is &#39;substantial doubt&#39; over its ability to continue as a going concern.</li>
<li>Acer Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acer#NASDAQ">ACER</a>) gained 21% to $1.90. Acer Therapeutics recently reported a $1.5 million private placement.</li>
<li>HUYA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) rose 20.6% to $3.39.</li>
<li>NeuroBo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nrbo#NASDAQ">NRBO</a>) shares rose 20.4% to $2.0907 after gaining 25% on Thursday. Ladenburg Thalmann recently initiated coverage on NeuroBo Pharmaceuticals with a Buy rating and announced a price target of $6.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ensc#NASDAQ">ENSC</a>) gained 19.2% to $1.1799.</li>
<li>SpringBig Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbig#NASDAQ">SBIG</a>) jumped 18.4% to $0.7578.</li>
<li>Powerbridge Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbts#NASDAQ">PBTS</a>) rose 18.3% to $0.1341. Powerbridge Technologies, last month, announced the strategic acquisition of DTI Group.</li>
<li>Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) gained 17.7% to $17.53 following better-than-expected Q3 results.</li>
<li>Armata Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/armp#NYSE">ARMP</a>) jumped 17.7% to $2.26.</li>
<li>Phreesia, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phr#NYSE">PHR</a>) rose 16.4% to $31.08 after the company posted upbeat Q3 sales and raised FY23 revenue guidance.</li>
<li>Braemar Hotels &amp; Resorts Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhr#NYSE">BHR</a>) gained 16.2% to $4.01. Braemar Hotels &amp; Resorts announced an increase in quarterly dividend from $0.01 per share to $0.05 per share and authorized $25 million for share repurchases.</li>
<li>DocuSign, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docu#NASDAQ">DOCU</a>) rose 15.8% to $50.68 after the company reported better-than-expected financial results for its third quarter and issued strong guidance. Piper Sandler upgraded the stock from Underweight to Neutral and lowered the price target from $54 to $50.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iclk#NASDAQ">ICLK</a>) gained 14.9% to $4.0901.</li>
<li>Johnson Outdoors Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jout#NASDAQ">JOUT</a>) jumped 12.8% to $64.83 following better-than-expected quarterly results.</li>
<li>Ikena Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikna#NASDAQ">IKNA</a>) gained 12.7% to $3.09.</li>
<li>Harpoon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/harp#NASDAQ">HARP</a>) jumped 11.8% to $1.07.</li>
<li>Ecoark Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zest#NASDAQ">ZEST</a>) gained 9.3% to $0.59.</li>
<li>WaveDancer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wavd#NASDAQ">WAVD</a>) jumped 9.3% to $0.66.</li>
<li>Korea Electric Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kep#NYSE">KEP</a>) rose 8.9% to $8.07.</li>
<li>National Beverage Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fizz#NASDAQ">FIZZ</a>) gained 8% to $52.33 following Q2 results.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) rose 8% to $0.5199 after dropping 13% on Thursday.</li>
<li>Broadcom Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgo#NASDAQ">AVGO</a>) gained 3.7% to $550.93 as the company reported better-than-expected results for its fourth quarter and issued strong sales forecast for the current quarter. Broadcom also raised the quarterly dividend by 12% to $4.60 per share.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>Getaround Inc. (NYSE: GETR) shares tumbled 64.8% to $3.10. Getaround reported closing of business combination with InterPrivate II Acquisition Corp.</li>
<li>Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>) dipped 58% to $1.6195. Grom Social Enterprises priced $5 million public offering of 1,415,682 units at a price of $2.89 per unit</li>
<li>Autolus Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/autl#NASDAQ">AUTL</a>) fell 34.9% to $1.9475 after the company announced pricing of a public offering. The company&rsquo;s Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukemia (ALL) has met its primary endpoint of Overall Remission Rate (ORR).</li>
<li>Meta Materials Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mmat#NASDAQ">MMAT</a>) dropped 24.6% to $1.3799. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META&#39;s Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.</li>
<li>My Size, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mysz#NASDAQ">MYSZ</a>) fell 24% to $3.61.</li>
<li>Winc, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wbev#NYSE">WBEV</a>) dropped 19% to $0.17.</li>
<li>Erasca, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eras#NASDAQ">ERAS</a>) fell 17.6% to $6.03 after the company priced a 15,384,616 share offering at $6.50 per share.</li>
<li>BioVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bivi#NASDAQ">BIVI</a>) dropped 16.9% to $7.56.</li>
<li>Flora Growth Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgc#NASDAQ">FLGC</a>) fell 16.8% to $0.37 after the company announced pricing of a $5 million registered direct offering.</li>
<li>Sunlands Technology Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stg#NYSE">STG</a>) declined 16.4% to $6.18.</li>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) fell 15% to $2.0150. Rent The Runway shares jumped 74% on Thursday after the company reported better-than-expected Q3 sales results.</li>
<li>Bluejay Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bjdx#NASDAQ">BJDX</a>) declined 15% to $0.45.</li>
<li>Save Foods, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svfd#NASDAQ">SVFD</a>) dipped 14.3% to $0.8999.</li>
<li>Pharvaris N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phvs#NASDAQ">PHVS</a>) shares fell 14.2% to $9.83. Pharvaris shares jumped 339% on Thursday after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks.</li>
<li>SHF Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shfs#NASDAQ">SHFS</a>) dropped 13.6% to $3.4995.</li>
<li>Sono Group N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sev#NASDAQ">SEV</a>) fell 13.2% to $0.9632. Sono Group shares dropped 5% on Thursday after the company reported worse-than-expected Q3 EPS results.</li>
<li>Torrid Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/curv#NYSE">CURV</a>) declined 13.1% to $3.7099 after the company reported worse-than-expected Q3 EPS and sales results and issued Q4 2022 and FY22 revenue guidance below estimates.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) dropped 12.3% to $0.9550. Tivic Health and Reliefband Technologies, LLC terminated acquisition agreement.</li>
<li>Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) fell 12.3% to $328.35. Lululemon posted upbeat results for its third quarter, but issued weak holiday-quarter guidance.</li>
<li>Party City Holdco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/prty#NYSE">PRTY</a>) fell 12.1% to $0.5210.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) shares fell 11.3% to $0.6441after declining over 25% on Thursday. TransCode Therapeutics recently announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.</li>
</ul>
Also check this out <a href="https://www.benzinga.com/markets/cryptocurrency/22/12/30022592/bitcoin-tops-this-key-level-the-graph-emerges-as-top-gainer"> Bitcoin Tops This Key Level; The Graph Emerges As Top Gainer</a>

ACER

ACLX

AMAM

ARMP

AUTL

AVGO

BJDX

BXRX

CJJD

CLRO

CURV

DAKT

DOCU

DOMO

ERAS

FIZZ

FLGC

GROM

HARP

HUYA

ICLK

IKNA

JOUT

LULU

MMAT

MOMO

MRIN

MYSZ

PBTS

PHVS

PRTY

RENT

RKLY

SBIG

SHF Holdings, Inc. - Class A Common Stock

SHFS

SVFD

SXTC

TIVC

WAVD

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session

Comments

Korea Electric Power

Korea Electric Power (KEP) Forecast

Korea Electric Power (NYSE:KEP) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga